Yuichiro Makita

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: Involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation

Shinji Hagiwara, Yuichiro Makita, Leyi Gu et al. · Nephrology Dialysis Transplantation · 2005 · 83 citations

Identification of Epistatic Interaction Involved in Obesity Using the KK/Ta Mouse as a Type 2 Diabetes Model

Tomohito Gohda, Yuichiro Makita, Toshihide Shike et al. · Diabetes · 2003 · 69 citations · Full text

Genetics, Immunology, Diabetes Model +19

Relationship between Polymorphism in the Angiotensinogen, Angiotensin-Converting Enzyme or Angiotensin II Receptor and Renal Progression in Japanese NIDDM Patients

Yasuhiko Tomino, Yuichiro Makita, Toshihide Shike et al. · ˜The œNephron journals/Nephron journals · 1999 · 64 citations

Hypertension, Genetic Epidemiology, Renal Inflammation +19

Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice

Mitsuo Tanimoto, Qiuling Fan, Tomohito Gohda et al. · Metabolism · 2004 · 64 citations

Kk/ta Mice, Metabolic Syndrome, Urology +11